These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17133509)

  • 1. Calcium phosphate bone cements, functionalized with VEGF: release kinetics and biological activity.
    Lode A; Wolf-Brandstetter C; Reinstorf A; Bernhardt A; König U; Pompe W; Gelinsky M
    J Biomed Mater Res A; 2007 May; 81(2):474-83. PubMed ID: 17133509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin modification of calcium phosphate bone cements for VEGF functionalization.
    Lode A; Reinstorf A; Bernhardt A; Wolf-Brandstetter C; König U; Gelinsky M
    J Biomed Mater Res A; 2008 Sep; 86(3):749-59. PubMed ID: 18041720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of different modifications of a calcium phosphate bone cement on adhesion, proliferation, and osteogenic differentiation of human bone marrow stromal cells.
    Vater C; Lode A; Bernhardt A; Reinstorf A; Heinemann C; Gelinsky M
    J Biomed Mater Res A; 2010 Mar; 92(4):1452-60. PubMed ID: 19373921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of different modifications of a calcium phosphate cement on resorption and new bone formation: an in vivo study in the minipig.
    Tödtmann N; Lode A; Mann R; Mai R; Lauer G; Wieczorek K; Eckelt U
    J Biomed Mater Res B Appl Biomater; 2013 Nov; 101(8):1410-8. PubMed ID: 23740800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralized poly(lactic acid) scaffolds loading vascular endothelial growth factor and the in vivo performance in rat subcutaneous model.
    Kim JH; Kim TH; Jin GZ; Park JH; Yun YR; Jang JH; Kim HW
    J Biomed Mater Res A; 2013 May; 101(5):1447-55. PubMed ID: 23114998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of modified extracellular matrices on TI6AL4V implants on binding and release of VEGF.
    Wolf-Brandstetter C; Lode A; Hanke T; Scharnweber D; Worch H
    J Biomed Mater Res A; 2006 Dec; 79(4):882-94. PubMed ID: 16941591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifications of a calcium phosphate cement with biomolecules--influence on nanostructure, material, and biological properties.
    Vater C; Lode A; Bernhardt A; Reinstorf A; Nies B; Gelinsky M
    J Biomed Mater Res A; 2010 Dec; 95(3):912-23. PubMed ID: 20845493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of VEGF loading on scaffold-confined vascularization.
    Lindhorst D; Tavassol F; von See C; Schumann P; Laschke MW; Harder Y; Bormann KH; Essig H; Kokemüller H; Kampmann A; Voss A; Mülhaupt R; Menger MD; Gellrich NC; Rücker M
    J Biomed Mater Res A; 2010 Dec; 95(3):783-92. PubMed ID: 20725981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering strategies to control vascular endothelial growth factor stability and levels in a collagen matrix for angiogenesis: the role of heparin sodium salt and the PLGA-based microsphere approach.
    d'Angelo I; Oliviero O; Ungaro F; Quaglia F; Netti PA
    Acta Biomater; 2013 Jul; 9(7):7389-98. PubMed ID: 23523534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
    Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
    J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF-induced angiogenesis following localized delivery via injectable, low viscosity poly(trimethylene carbonate).
    Amsden BG; Timbart L; Marecak D; Chapanian R; Tse MY; Pang SC
    J Control Release; 2010 Jul; 145(2):109-15. PubMed ID: 20381557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis.
    Chai J; Jones MK; Tarnawski AS
    FASEB J; 2004 Aug; 18(11):1264-6. PubMed ID: 15180964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of combined delivery of recombinant human bone morphogenetic protein-2 and recombinant human vascular endothelial growth factor 165 from biomimetic calcium-phosphate-coated implants on osseointegration.
    Ramazanoglu M; Lutz R; Ergun C; von Wilmowsky C; Nkenke E; Schlegel KA
    Clin Oral Implants Res; 2011 Dec; 22(12):1433-9. PubMed ID: 21418332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF incorporated into calcium phosphate ceramics promotes vascularisation and bone formation in vivo.
    Wernike E; Montjovent MO; Liu Y; Wismeijer D; Hunziker EB; Siebenrock KA; Hofstetter W; Klenke FM
    Eur Cell Mater; 2010 Feb; 19():30-40. PubMed ID: 20178096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium phosphate cements loaded with basic fibroblast growth factor: delivery and in vitro cell response.
    Perez RA; Kim TH; Kim M; Jang JH; Ginebra MP; Kim HW
    J Biomed Mater Res A; 2013 Apr; 101(4):923-31. PubMed ID: 22962037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
    Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T
    Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled release of local anesthetic from calcium phosphate bone cements.
    Irbe Z; Loca D; Vempere D; Berzina-Cimdina L
    Mater Sci Eng C Mater Biol Appl; 2012 Aug; 32(6):1690-4. PubMed ID: 24364978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor release from alginate microspheres under simulated physiological compressive loading and the effect on human vascular endothelial cells.
    Li Q; Hou T; Zhao J; Xu J
    Tissue Eng Part A; 2011 Jul; 17(13-14):1777-85. PubMed ID: 21341993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin modification of a biomimetic bone matrix for controlled release of VEGF.
    Knaack S; Lode A; Hoyer B; Rösen-Wolff A; Gabrielyan A; Roeder I; Gelinsky M
    J Biomed Mater Res A; 2014 Oct; 102(10):3500-11. PubMed ID: 24178515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor.
    Steffens GC; Yao C; Prével P; Markowicz M; Schenck P; Noah EM; Pallua N
    Tissue Eng; 2004; 10(9-10):1502-9. PubMed ID: 15588409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.